Nutraceutical CDMOs · capability heat map (62 partners)

Capsule capability is broadly distributed across the 62 partners — 87% offer hard-shell capsule fill at scale. Vegetarian (HPMC) capsule capability is narrower at 64%.

Tablet capability is similarly broad but compressed-tablet expertise (the harder discipline) sits with only 41% of partners.

Only 34% have meaningful gummy lines. Pectin-based gummy capacity is even rarer at 18%.

Effervescent specialists concentrate in West and South India and require controlled-humidity rooms — capital-intensive infrastructure that limits new entrants.

Powder blending capacity above 500kg/batch sits with only 18 of the 62 partners.

Maharashtra (Aurangabad, Pune) and Gujarat (Ahmedabad, Vadodara) together host 48% of mapped partners. Tamil Nadu and Karnataka another 26%. The remaining 26% spread across North and East.

Regional concentration matters for freight cost and audit travel — brands shipping nationally should consider partner location relative to primary distribution centre.

FSSAI Nutra licence is near-universal (92%). GMP at 78%. WHO-GMP at 34%. NSF certification at 12% — a meaningful filter for export-bound brands.

Halal certification at 38%, expanding rapidly as brands target Middle East export.

Brands looking for top-quartile partners should filter on three combined criteria: (1) GMP + WHO-GMP, (2) in-house testing lab, (3) minimum batch size ≤ 5,000 units for flexibility.

Only 11 of 62 partners meet all three. They command 8 – 14% pricing premium but unlock materially faster time-to-market and lower defect rates.

Hard-shell capsule: 54 partners (87%), combined weekly capacity ~280M caps

Compressed tablet: 25 partners (41%), combined weekly ~120M tabs

Gummy (gelatin): 21 partners (34%), combined weekly ~18M gummies

Gummy (pectin): 11 partners (18%), combined weekly ~8M gummies

Effervescent: 17 partners (27%), combined weekly ~24M tabs

Powder ≥500kg batch: 18 partners (29%), combined weekly ~340 MT